Prevalence of CKD in normal-weight and overweight/obese subpopulation.

<p>Prevalence of CKD in normal-weight and overweight/obese subpopulation.</p

Prevalence of CKD in normal-weight and overweight/obese subpopulation according to IR.

<p>Prevalence of CKD in normal-weight and overweight/obese subpopulation according to IR.</p

Prevalence of metabolic syndrome in normal-weight and overweight/obese subpopulation.

<p>Prevalence of metabolic syndrome in normal-weight and overweight/obese subpopulation.</p

Baseline assessments of ACHBLF patients and healthy subjects.

<p>Test of normality is done by Kolmogorov-Smirnov Test.</p>*<p>P>0.05.</p

Prevalence of insulin resistance in normal-weight and overweight/obese subpopulation.

<p>Prevalence of insulin resistance in normal-weight and overweight/obese subpopulation.</p

LPS levels in different disease phases compared to those in the healthy group.

<p>LPS levels in different disease phases compared to those in the healthy group.</p

Total bilirubin, MELD-Na scores, and LPS levels in different phases of ACHBLF.

<p>MELD-Na score correlated with LPS in the progression phase (*p = 0.01, R = 0.876) and in the peak phase, (**p = 0.000, R = −1.00), respectively.</p